Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
J Thromb Haemost. 2022 Nov;20(11):2587-2600. doi: 10.1111/jth.15827. Epub 2022 Aug 7.
Within the vasculature platelets and endothelial cells play crucial roles in hemostasis and thrombosis. Platelets, like endothelial cells, possess intermediate conductance Ca -activated K (IK ) channels and generate nitric oxide (NO). Although NO limits platelet aggregation, the role of IK channels in platelet function and NO generation has not yet been explored.
We investigated whether IK channel activation inhibits platelet aggregation, and per endothelial cells, enhances platelet NO production.
Platelets were isolated from human volunteers. Aggregometry, confocal microscopy, and a novel flow chamber model, the Quartz Crystal Microbalance (QCM) were used to assess platelet function. Flow cytometry was used to measure platelet NO production, calcium signaling, membrane potential, integrin α /β activation, granule release, and procoagulant platelet formation.
Platelet IK channel activation with SKA-31 inhibited aggregation in a concentration-dependent manner, an effect reversed by the selective IK channel blocker TRAM-34. The QCM model along with confocal microscopy demonstrated that SKA-31 inhibited platelet aggregation under flow conditions. Surprisingly, IK activation by SKA-31 inhibited platelet NO generation, but this could be explained by a concomitant reduction in platelet calcium signaling. IK activation by SKA-31 also inhibited dense and alpha-granule secretion and integrin α /β activation, but maintained platelet phosphatidylserine surface exposure as a measure of procoagulant response.
Platelet IK channel activation inhibits aggregation by reducing calcium-signaling and granule secretion, but not by enhancing platelet NO generation. IK channels may be novel targets for the development of antiplatelet drugs that limit atherothrombosis, but not coagulation.
在血管中,血小板和内皮细胞在止血和血栓形成中起着至关重要的作用。血小板与内皮细胞一样,具有中等电导钙激活钾(IK)通道,并产生一氧化氮(NO)。尽管 NO 限制了血小板聚集,但 IK 通道在血小板功能和 NO 生成中的作用尚未得到探索。
我们研究了 IK 通道激活是否抑制血小板聚集,以及内皮细胞增强血小板 NO 生成。
从人类志愿者中分离血小板。使用聚集仪、共聚焦显微镜和新型流动室模型(Quartz Crystal Microbalance,QCM)来评估血小板功能。使用流式细胞术测量血小板 NO 生成、钙信号、膜电位、整合素 α/β 激活、颗粒释放和促凝血小板形成。
血小板 IK 通道激活剂 SKA-31 以浓度依赖性方式抑制聚集,该作用可被选择性 IK 通道阻滞剂 TRAM-34 逆转。QCM 模型结合共聚焦显微镜表明,SKA-31 在流动条件下抑制血小板聚集。令人惊讶的是,SKA-31 激活 IK 会抑制血小板 NO 生成,但这可以通过血小板钙信号的同时减少来解释。SKA-31 激活 IK 还抑制致密和α-颗粒分泌以及整合素 α/β 激活,但保持血小板磷脂酰丝氨酸表面暴露作为促凝反应的指标。
血小板 IK 通道激活通过减少钙信号和颗粒分泌来抑制聚集,但不会通过增强血小板 NO 生成来抑制聚集。IK 通道可能是开发抗血小板药物的新靶点,这些药物可以限制动脉血栓形成,但不会影响凝血。